Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

cdsco

  1. Home>
  2. News>
  3. cdsco>
  4. Page 12

How to Verify Legitimate Indian Generic Medicine Suppliers: A 2026 Buyer’s Guide

  • Post published:July 16, 2026
  • Post category:Knowledge

The global demand for Indian generic medicines continues to surge in 2026, driven by India's position as the "Pharmacy of the World" — supplying over 20% of the world's generic…

Continue Reading How to Verify Legitimate Indian Generic Medicine Suppliers: A 2026 Buyer’s Guide

How to Read Drug Quality Certificates for Indian Generic Medicines: A 2026 Buyer’s Guide

  • Post published:July 15, 2026
  • Post category:Knowledge

When buying generic medicines from India, verifying the quality and authenticity of the products is paramount. Unlike brand-name drugs, generics rely on documented evidence of bioequivalence, Good Manufacturing Practices (GMP),…

Continue Reading How to Read Drug Quality Certificates for Indian Generic Medicines: A 2026 Buyer’s Guide

India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%

  • Post published:July 14, 2026
  • Post category:News

The Indian pharmaceutical sector enters the second half of 2026 with significant momentum as three major developments converge: the India-UK Comprehensive Economic Trade Agreement (CETA) taking effect on July 15,…

Continue Reading India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%

Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide

  • Post published:July 5, 2026
  • Post category:Knowledge

For international buyers, healthcare professionals, and procurement specialists, navigating the quality assurance landscape of generic medicines can be complex. One of the most globally recognized benchmarks for pharmaceutical quality is…

Continue Reading Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide
  • Go to the previous page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 20
  • Go to the next page

Recent Posts

  • Schedule M 2026 Explained: GMP Compliance Rules for Indian Pharma
    September 13, 2026/
    0 Comments
  • CDSCO Adopts Risk-Based Drug Regulation Framework in India
    September 12, 2026/
    0 Comments
  • How to Verify Generic Medicine Quality: A Practical Buyer’s Checklist for India
    September 8, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • Schedule M 2026 Explained: GMP Compliance Rules for Indian Pharma
  • CDSCO Adopts Risk-Based Drug Regulation Framework in India
  • How to Verify Generic Medicine Quality: A Practical Buyer’s Checklist for India
  • Piyush Goyal Urges Indian Pharma to Move Beyond Generics into High-Value Medicines
  • Understanding India’s NDCT Rules 2026 Amendments: A Guide for Pharma Buyers

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve